Around the Web

Around the Web — 4.18.23

The emerging SARS-CoV-2 subvariant XBB.1.16 may carry the previously rare symptom of conjunctivitis, according to a pediatrician in India and a news report in the

Read More »

Around the Web — 4.4.23

FDA announced yesterday it is requiring manufacturers of opioid analgesics dispensed in outpatient settings to make prepaid mail-back envelopes available to outpatient pharmacies and other

Read More »

Around the Web — 3.30.23

FDA yesterday approved Emergent BioSolutions’ Narcan (naloxone hydrochloride) 4 mg nasal spray for OTC use. The action “paves the way for the life-saving medication to

Read More »

Around the Web — 3.15.23

Children 6 months to 4 years of age are now eligible to receive a single booster dose of the Pfizer-BioNTech COVID-19 Vaccine, Bivalent, as a

Read More »

Around the Web — 3.8.23

The FDA has unveiled its new Dietary Supplement Ingredient Directory, a webpage where the public can look up ingredients used in products marketed as dietary

Read More »

Around the Web — 2.23.23

The 2022–23 influenza vaccine has provided reasonable protection against infection and hospitalization caused by infection, members of the CDC’s Advisory Committee on Immunization Practices heard

Read More »

Around the Web — 2.22.23

FDA on Friday granted accelerated approval to sparsentan (Filspari, Travere Therapeutics) to reduce proteinuria in adults with primary IgA nephropathy (IgAN) at risk of rapid

Read More »

Around the Web — 2.21.23

FDA last week approved velmanase alfa (Lamzede), the first enzyme replacement therapy approved in the U.S. for the treatment of non-central nervous system manifestations of alpha-mannosidosis,

Read More »

Around the Web — 2.16.23

With the federal public health emergency ending on May 11, the U.S. Department of Health and Human Services has released a “transition roadmap” that discusses

Read More »

Around the Web — 2.6.23

The FDA last week dropped the emergency use authorization requirement that patients have positive test results before prescribing of the antiviral products ritonavir-boosted nirmatrelvir (Paxlovid)

Read More »